Seems like great timing to go for uplist now. We have more cash than we have ever had, higher SP, and volume of shares traded daily is great. Only unfortunate thing is we may get our covid19 trial results before the uplist. But it's hard to believe that funds won't bend their rules a bit when they see how strong the MOA of leronlimab is. Good call by NP waiting till now to make the leap.